|
(Health-NewsWire.Net, November 26, 2015 ) Psoriasis is a chronic, immune-mediated inflammatory skin disease. Psoriasis ranges in severity from a few scattered, sharply demarcated, scaly, red, coin-sized skin lesions or scaly plaques to involvement of almost the entire body surface. Psoriasis is more prevalent in colder areas, and less prevalent in the tropics and warmer regions of the world. Globally, the one-year prevalence of psoriasis varies with the differences in prevalence of psoriasis attributed to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=466519
GlobalData epidemiologists forecast an increase in the one-year diagnosed prevalent cases of psoriasis in the 8MM, from 43,747,201 cases in 2014 to 50,455,013 cases in 2024, with an Annual Growth Rate (AGR) of 1.53% during the forecast period. In 2024, India will have the highest number of one-year diagnosed prevalent cases of psoriasis in the 8MM, with 32,853,676 cases, whereas Japan will have the lowest number of one-year diagnosed prevalent cases of psoriasis, with 482,431 cases in 2024.
This report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM.
Scope
- The Psoriasis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM. GlobalData epidemiologists forecast the one-year diagnosed prevalent cases of psoriasis in the 8MM from 20142024 using data obtained from peer-reviewed journals that provide one-year diagnosed prevalence of psoriasis in the respective markets. Psoriasis one-year diagnosed prevalent cases are further segmented by severity.
- The psoriasis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy
The Psoriasis EpiCast series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
- Quantify patient populations in the global psoriasis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for psoriasis therapeutics in each of the markets covered.
Browse Detail Report With TOC @ http://www.researchmoz.us/epicast-report-psoriasis-epidemiology-forecast-to-2024-report.html
Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 10
3.3.1 Prevalence 10
3.4 Forecast Methodology 12
3.4.1 Sources Used for One-Year Diagnosed Prevalence of Psoriasis 13
3.4.2 Sources Not Used 16
3.4.3 Forecast Assumptions and Methods, One-Year Diagnosed Prevalent Cases of Psoriasis 17
3.5 Epidemiological Forecast for Psoriasis (2014-2024) 19
3.5.1 One-Year Diagnosed Prevalent Cases of Psoriasis 19
3.5.2 Age-Specific One-Year Diagnosed Prevalent Cases of Psoriasis 21
3.5.3 Sex-Specific One-Year Diagnosed Prevalent Cases of Psoriasis 23
3.5.4 Age-Standardized One-Year Diagnosed Prevalent Cases of Psoriasis 26
3.5.5 One-Year Diagnosed Prevalent Cases of Psoriasis by Severity 27
3.6 Discussion 28
3.6.1 Epidemiological Forecast Insight 28
3.6.2 Limitations of the Analysis 29
3.6.3 Strengths of the Analysis 29
4 Appendix 30
4.1 Bibliography 30
4.2 About the Authors 34
4.2.1 Epidemiologists 34
4.2.2 Reviewers 34
4.2.3 Global Director of Therapy Analysis and Epidemiology 35
4.2.4 Global Head of Healthcare 36
4.3 About GlobalData 37
4.4 About EpiCast 37
4.5 Disclaimer 38
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=466519
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
|
